Sapporo Clinical Laboratory Inc.

9776

JP3321100004

Drug Retailers

Delayed Japan Exchange Other stock markets 02:11:47 18/07/2024 BST			5-day change	1st Jan Change
1,012 ^JPY	+0.40%		+0.30%	+1.10%

03-27	Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.	CI
03-26	Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.	CI

Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.

June 20, 2021

The Board of Directors of Sapporo Clinical Laboratory Inc. has authorized a buyback plan on June 21, 2021.

Latest news about Sapporo Clinical Laboratory Inc.

Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.	03-27	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.	03-25	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 232,100 shares, representing 6.97% for ¥209.12 million.	02-26	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	02-25	CI
Sapporo Clinical Laboratory Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23	CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022.	31/05/22	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on May 30, 2022 has closed with 22,700 shares, representing 0.67% for ¥29.21 million.	30/05/22	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 22,700 shares, representing 0.68% for ¥29.21 million.	30/05/22	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	29/05/22	CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 28, 2022.	01/03/22	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 28, 2022, has closed with 53,700 shares, representing 1.58% for ¥69.11 million.	28/02/22	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 53,700 shares, representing 1.58% for ¥69.11 million.	28/02/22	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	27/02/22	CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 21, 2021.	22/06/21	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 21, 2021, has closed with 16,300 shares, representing 0.48% for ¥25.92 million.	21/06/21	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 16,300 shares, representing 0.48% for ¥25.92 million.	21/06/21	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	20/06/21	CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 26, 2018.	27/06/18	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 26, 2018 has expired with 39,200 shares, representing 1.13% for ¥96 million.	26/06/18	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 45,000 shares, representing 1.3% for ¥110.21 million.	26/06/18	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	25/06/18	CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2018.	27/02/18	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 26, 2018 has expired with 16,800 shares for ¥32.26 million.	26/02/18	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 20,000 shares, representing 0.57% for ¥38.4 million.	26/02/18	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	25/02/18	CI

Chart Sapporo Clinical Laboratory Inc.

Duration

Period

More charts

SAPPORO CLINICAL LABORATORY INC. is a Japan-based company mainly engaged in the dispensing pharmacy business. The Company operates in three business segments. The Clinical Examination segment is engaged in the provision of clinical examination needed in medical examinations in hospitals. The Dispensing Pharmacy segment is engaged in operation of dispensing pharmacies, as well as wholesale of drugs and medicines. The Medical Equipment Sale and Maintenance segment is engaged in the sale and maintenance of high level medical equipment, general medical equipment, as well as physics and chemistry equipment. The others business is engaged in the development, sale and maintenance of software for clinical examination system.

Sector

Drug Retailers

Calendar

04/08/2024 - Q1 2024 Earnings Release

More about the company

	1st Jan change	Capi.
SAPPORO CLINICAL LABORATORY INC.	+1.10%	21.44M
RAIA DROGASIL S.A.	-12.89%	8.03B
AIN HOLDINGS INC.	+26.82%	1.24B
QOL HOLDINGS CO., LTD.	-7.48%	363M
NIHON CHOUZAI CO.,LTD.	+6.86%	287M
SALUS, LJUBLJANA, D. D.	+8.33%	225M
PETMED EXPRESS, INC.	-47.95%	78.21M
GREEN CROSS HEALTH LIMITED	-28.44%	68.02M
MEDICAL IKKOU GROUP CO.,LTD.	+28.50%	64.73M

Retail - Drugs without Grocery